Supplementation therapy and Photophobia
Summary:
Photophobia is found among people with Supplementation therapy, especially for people who are male, 30-39 old.
The study analyzes which people have Photophobia with Supplementation therapy. It is created by eHealthMe based on reports of 143 people who have Supplementation therapy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Supplementation therapy?
Supplementation therapy is found to be associated with 3 drugs and 7 conditions by eHealthMe. Check the latest studies of Supplementation therapy.
What is Photophobia?
Photophobia (extreme sensitivity to light) is found to be associated with 1,295 drugs and 1,831 conditions by eHealthMe. Check the latest studies of Photophobia.
143 people who have Supplementation Therapy and Photophobia are studied.

Gender of people who have Supplementation therapy and experienced Photophobia *:
Age of people who have Supplementation therapy and experienced Photophobia *:
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Photophobia?
- Check whether Photophobia is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Supplementation therapy (40,925 reports)
- Photophobia (21,346 reports)
All the drugs that are associated with Photophobia:
- Photophobia (1,295 drugs)
All the conditions that are associated with Photophobia:
- Photophobia (1,831 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Photophobia and Supplementation therapy, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Avandamet cause Hot Flush? - 3 seconds ago
- Could Glucagon cause Pain? - 10 seconds ago
- Could Cerezyme cause Pain? - 16 seconds ago
- Aplastic Anemia and Pain - 24 seconds ago
- Joint Pain and Hypotension - 28 seconds ago
- Drug interactions of Acetaminophen And Hydrocodone Bitartrate and Metronidazole - 29 seconds ago
- Could Guaifenesin cause Abnormal Dreams? - 33 seconds ago
- Could Antivert cause Osteolysis? - 40 seconds ago
- Hydralazine And Hydrochlorthiazide vs. Spironolactone And Hydrochlorothiazide, side effect and effectiveness comparison - 46 seconds ago
- Nasal Congestion and Thrombocytopenia - 56 seconds ago